ALCON INCALCEarnings & Financial Report
NYSE · pharmaceutical industry
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
NextMar 31, 2026
ALC Q2 2025 Key Financial Metrics
营收
$2.6B
毛利润
$1.4B
营业利润
$247.0M
净利润
$176.0M
毛利率
53.5%
营业利润率
9.5%
净利率
6.8%
同比增长
4.0%
EPS
$0.35
资金流向
ALCON INC Q2 2025 Financial Summary
ALCON INC reported revenue of $2.6B for Q2 2025, with a net profit of $176.0M (6.8% margin). Cost of goods sold was $1.2B, operating expenses totaled $1.1B.
Key Financial Metrics
| Total Revenue | $2.6B |
|---|---|
| Net Profit | $176.0M |
| Gross Margin | 53.5% |
| Operating Margin | 9.5% |
| Report Period | Q2 2025 |
利润表
| Q2 2022 | Q2 2023 | Q2 2024 | Q2 2025 | |
|---|---|---|---|---|
| 营收 | $2.22B | $2.42B | $2.50B | $2.60B |
| 同比增长 | 5.1% | 9.2% | 3.1% | 4.0% |
资产负债表
| Q2 2022 | Q2 2023 | Q2 2024 | Q2 2025 | |
|---|---|---|---|---|
| 总资产 | $27.73B | $29.21B | $29.72B | $31.39B |
| 总负债 | $8.19B | $9.27B | $8.78B | $9.26B |
| 股东权益 | $19.54B | $19.94B | $20.94B | $22.13B |
现金流量表
No data available for this period
